Healthcare provider profile · identity verified

Candido Gamez, M.D.

Family Practice · SAN DIMAS, CA · NPI 1689625972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	912	349
Lisinopril	Lisinopril	393	163
Amlodipine Besylate	Amlodipine Besylate	286	105
Losartan Potassium	Losartan Potassium	238	99
Metformin Hcl Er	Metformin Hcl	237	97
Levothyroxine Sodium	Levothyroxine Sodium	232	92
Omeprazole	Omeprazole	217	98
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	195	78
Rosuvastatin Calcium	Rosuvastatin Calcium	192	80
Metformin Hcl	Metformin Hcl	171	70
Hydrochlorothiazide	Hydrochlorothiazide	161	70
Alendronate Sodium	Alendronate Sodium	159	62
Simvastatin	Simvastatin	157	65
Atenolol	Atenolol	153	58
Terazosin Hcl	Terazosin Hcl	151	57
Glipizide	Glipizide	143	60
Metoprolol Tartrate	Metoprolol Tartrate	114	43
Tamsulosin Hcl	Tamsulosin Hcl	80	32
Pioglitazone Hcl	Pioglitazone Hcl	79	32
Gabapentin	Gabapentin	75	29
Allopurinol	Allopurinol	69	26
Albuterol Sulfate Hfa	Albuterol Sulfate	68	47
Famotidine	Famotidine	68	34
Jardiance	Empagliflozin	67	31
Potassium Chloride	Potassium Chloride	65	28
Humulin N	Insulin Nph Human Isophane	57	23
Pradaxa	Dabigatran Etexilate Mesylate	56	23
Clopidogrel	Clopidogrel Bisulfate	53	16
Pantoprazole Sodium	Pantoprazole Sodium	51	23
Montelukast Sodium	Montelukast Sodium	47	22
Triamcinolone Acetonide	Triamcinolone Acetonide	43	26
Meloxicam	Meloxicam	40	25
Trazodone Hcl	Trazodone Hcl	40	14
Furosemide	Furosemide	38	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	38	16
Bisoprolol Fumarate	Bisoprolol Fumarate	36	16
Humulin N Kwikpen	Insulin Nph Human Isophane	35	11
Hydralazine Hcl	Hydralazine Hcl	35	15
Fluoxetine Hcl	Fluoxetine Hcl	31	13
Doxycycline Monohydrate	Doxycycline Monohydrate	30	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	15
Carvedilol	Carvedilol	29	14
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	13
Wixela Inhub	Fluticasone Propion/Salmeterol	25	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Finasteride	Finasteride	22	11
Fluticasone Propionate	Fluticasone Propionate	22	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Lorazepam	Lorazepam	18	suppressed
Alvesco	Ciclesonide	17	11
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Prednisone	Prednisone	17	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	17
Tramadol Hcl	Tramadol Hcl	17	suppressed
Cefadroxil	Cefadroxil	16	16
Memantine Hcl	Memantine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Cephalexin	Cephalexin	14	14
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Lactulose	Lactulose	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	13
Clonidine Hcl	Clonidine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	12
Eliquis	Apixaban	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Sitagliptin	Sitagliptin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error